CVE-2025-2230

Philips Intellispace Cardiovascular (ISCV) Improper Authentication

Description

A flaw exists in the Windows login flow where an AuthContext token can be exploited for replay attacks and authentication bypass.

Remediation

Solution:

  • Philips recommends the following mitigations: * Resolved in ISCV 5.2, which was released in September 2020. * Philips recommends users upgrade ISCV installed base to the latest ISCV version (at the time of this publication is 830089 – IntelliSpace Cardiovacular 8.0.0.0) * Please contact a local Philips sales (service) representative to learn how to engage this upgrade process. * For managed services users, new releases will be made available upon resource availability. Releases are subject to country-specific regulations. Refer to the Philips advisory https://www.philips.com/a-w/security/security-advisories.html for more details.

Category

8.5
CVSS
Severity: High
CVSS 4.0 •
CVSS 3.1 •
EPSS 0.03%
Affected: Philips Intellispace Cardiovascular (ISCV)
Published at:
Updated at:

References

Link Tags
https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-072-01
https://www.philips.com/a-w/security/security-advisories.html

Frequently Asked Questions

What is the severity of CVE-2025-2230?
CVE-2025-2230 has been scored as a high severity vulnerability.
How to fix CVE-2025-2230?
To fix CVE-2025-2230: Philips recommends the following mitigations: * Resolved in ISCV 5.2, which was released in September 2020. * Philips recommends users upgrade ISCV installed base to the latest ISCV version (at the time of this publication is 830089 – IntelliSpace Cardiovacular 8.0.0.0) * Please contact a local Philips sales (service) representative to learn how to engage this upgrade process. * For managed services users, new releases will be made available upon resource availability. Releases are subject to country-specific regulations. Refer to the Philips advisory https://www.philips.com/a-w/security/security-advisories.html for more details.
Is CVE-2025-2230 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2025-2230 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-2230?
CVE-2025-2230 affects Philips Intellispace Cardiovascular (ISCV).
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.